Related Experiment Video
Updated: Jan 19, 2026

11:37
Zika Virus Specific Diagnostic Epitope Discovery
Published on: December 12, 2017
8.3K
Computationally Designed Peptides for Zika Virus Detection: An Incremental Construction Approach.
Marcello Mascini1,2, Emre Dikici3,4, Marta Robles Mañueco5
1Department of Analytical Chemistry, Faculty of Chemistry, University Complutense of Madrid, Ciudad Universitaria s/n, 28040 Madrid, Spain. mmascini@unite.it.
Biomolecules
|September 20, 2019
Summary
Researchers developed peptide-based biomimetic antibodies for Zika virus (ZIKV) detection. Three peptides showed sensitive ZIKV detection in biological samples, offering a promising alternative to traditional antibodies.
Area of Science:
- Virology
- Biotechnology
- Immunology
Background:
- Current anti-Zika virus (ZIKV) antibody production methods face limitations.
- Developing novel diagnostic tools for ZIKV detection is crucial.
Purpose of the Study:
- To propose a semi-combinatorial virtual strategy for selecting short peptides as biomimetic antibodies for intact ZIKV particle detection.
- To evaluate the efficacy of synthesized peptides in detecting ZIKV and discriminating it from Dengue virus (DENV).
Main Methods:
- A virtual strategy involving docking cycles of tetra, penta, hexa, and heptapeptide libraries was employed.
- Peptide libraries were designed to maximize discrimination between ZIKV and DENV envelope protein glycosylation sites.
- Synthesized peptides were tested against intact ZIKV and DENV particles using direct enzyme-linked immunosorbent assay (ELISA).
Main Results:
- Three synthesized peptides demonstrated good detection limits for intact ZIKV particles, with a dynamic range starting from 10^5 copies/mL.
- These peptides exhibited slight cross-reactivity with DENV serotypes at 10^6 copies/mL, but discrimination was lost at higher concentrations.
- Peptide sensitivity in biological matrices (serum, urine) decreased by one order of magnitude, with detection limits around 10^6 copies/mL for ZIKV.
Conclusions:
- The developed peptide-based assays show potential as sensitive diagnostic tools for ZIKV detection.
- These biomimetic antibodies offer a promising alternative to conventional antibodies for ZIKV diagnostics.
- Further research may optimize peptide sequences for enhanced specificity and sensitivity in clinical applications.

